Katie L Burkhouse1, Autumn Kujawa1, Amy E Kennedy1,2, Stewart A Shankman3, Scott A Langenecker1, K Luan Phan1,2,3, Heide Klumpp1,3. 1. Mood and Anxiety Disorders Research Program, Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois. 2. Mental Health Service, Jesse Brown VA Medical Center, Chicago, Illinois. 3. Departments of Psychology and Psychiatry, University of Illinois at Chicago, Chicago, Illinois.
Abstract
BACKGROUND: Cognitive behavioral therapy (CBT) is a well-established treatment for anxiety and depression; however, response to CBT is heterogeneous across patients and many remain symptomatic after therapy, raising the need to identify prospective predictors for treatment planning. Altered neural processing of reward has been implicated in both depression and anxiety, and improving hedonic capacity is a goal of CBT. However, little is known about how neural response to reward relates to CBT outcomes in depression and anxiety. The current study used the reward positivity (RewP) event-related potential (ERP) component to examine whether neural reactivity to reward would predict CBT response in a sample of patients with anxiety without depression (n = 30) and comorbid anxiety and depression (CAD, n = 22). METHODS: Participants completed a guessing reward ERP paradigm before completing 12 weeks of standard CBT. RESULTS: The majority of the sample (68%; 35 out of 52 patients) responded to treatment, and those with a reduced RewP at baseline were more likely to respond to treatment. A reduced RewP was also associated with a greater pre-to-post CBT reduction in depressive symptoms among individuals with CAD, but not among individuals with pure anxiety. CONCLUSIONS: CBT may be most beneficial in reducing depressive symptoms for individuals who demonstrate decreased reward reactivity prior to treatment. CBT may target reward brain function, leading to greater improvement in symptoms. These effects may be strongest, and therefore most meaningful, for individuals with reward-processing deficits prior to treatment.
BACKGROUND: Cognitive behavioral therapy (CBT) is a well-established treatment for anxiety and depression; however, response to CBT is heterogeneous across patients and many remain symptomatic after therapy, raising the need to identify prospective predictors for treatment planning. Altered neural processing of reward has been implicated in both depression and anxiety, and improving hedonic capacity is a goal of CBT. However, little is known about how neural response to reward relates to CBT outcomes in depression and anxiety. The current study used the reward positivity (RewP) event-related potential (ERP) component to examine whether neural reactivity to reward would predict CBT response in a sample of patients with anxiety without depression (n = 30) and comorbid anxiety and depression (CAD, n = 22). METHODS:Participants completed a guessing reward ERP paradigm before completing 12 weeks of standard CBT. RESULTS: The majority of the sample (68%; 35 out of 52 patients) responded to treatment, and those with a reduced RewP at baseline were more likely to respond to treatment. A reduced RewP was also associated with a greater pre-to-post CBT reduction in depressive symptoms among individuals with CAD, but not among individuals with pure anxiety. CONCLUSIONS: CBT may be most beneficial in reducing depressive symptoms for individuals who demonstrate decreased reward reactivity prior to treatment. CBT may target reward brain function, leading to greater improvement in symptoms. These effects may be strongest, and therefore most meaningful, for individuals with reward-processing deficits prior to treatment.
Authors: David C Mohr; Stacey L Hart; Laura Julian; Claudine Catledge; Lara Honos-Webb; Lea Vella; Edwin T Tasch Journal: Arch Gen Psychiatry Date: 2005-09
Authors: Autumn Kujawa; Katie L Burkhouse; Shannon R Karich; Kate D Fitzgerald; Christopher S Monk; K Luan Phan Journal: J Child Adolesc Psychopharmacol Date: 2019-05-07 Impact factor: 2.576
Authors: Estee M Hausman; Roman Kotov; Greg Perlman; Greg Hajcak; Ellen M Kessel; Daniel N Klein Journal: J Affect Disord Date: 2018-04-05 Impact factor: 4.839
Authors: Nili Solomonov; Jennifer N Bress; Jo Anne Sirey; Faith M Gunning; Christoph Flückiger; Patrick J Raue; Patricia A Areán; George S Alexopoulos Journal: Am J Geriatr Psychiatry Date: 2019-01-10 Impact factor: 4.105
Authors: Katie L Burkhouse; Stephanie M Gorka; Heide Klumpp; Amy E Kennedy; Shannon Karich; Jennifer Francis; Olusola Ajilore; Michelle G Craske; Scott A Langenecker; Stewart A Shankman; Greg Hajcak; K Luan Phan Journal: J Clin Psychiatry Date: 2018-06-12 Impact factor: 4.384